Skip to main content
TipRanks
Go Ultimate75% OFF

Ecovyst (ECVT) Q3 2026 Earnings Report

195 Followers

ECVT Q3 2026 EPS Results

Actual EPS
$0.23
Consensus EPS
$0.21
Beat/Miss
Beat by +$0.02
One Year Ago EPS
$0.19

ECVT Q3 2026 Revenue Results

Actual Revenue
$308.64M
Expected Revenue
$287.45M
Beat/Miss
Beat by +$21.18M
YoY Revenue Growth
+50.62%

Earnings Announcement Details

Quarter
Q3 2026
Date
11/05/2026
Time
Before Open
Conference Call
Thursday, November 5, 2026
ECVT Upcoming Earnings

Ecovyst's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

ECVT Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

Q3 2026
Earnings Call Date:Nov 05, 2026|% Change Since:7.82%|
Earnings Call Sentiment|Positive

The call was strongly positive overall. Highlights significantly outweighed the lowlights, with third-quarter adjusted EBITDA above guidance, higher sales, raised full-year sales and EBITDA outlooks, improved free cash flow guidance, favorable demand trends, strong liquidity, successful Calabrian integration, and planned share repurchases. The main challenges were lower reported EBITDA margin due to sulfur-cost pass-through, higher operating and turnaround costs, potential unplanned outages from deferred maintenance, lower fourth-quarter virgin sulfuric acid volume, and year-end destocking caution.

Company Guidance

Ecovyst raised full year 2026 sales guidance to $1.05 billion to $1.07 billion, compared with previous guidance of $1.02 billion to $1.06 billion; adjusted EBITDA guidance to $208 million to $212 million, compared with prior guidance of $195 million to $207 million; adjusted free cash flow guidance to $50 million to $60 million, up from $45 million to $55 million; interest expense to $19 million to $21 million; capital expenditures to $90 million to $95 million, compared with $85 million to $95 million; depreciation and amortization to $84 million to $88 million, compared with $80 million to $84 million; adjusted net income to $70 million to $85 million; and adjusted diluted net income per share to $0.63 to $0.77, up from $0.58 to $0.72. The company continues to expect its full year 2026 effective tax rate to be in the mid-20% range and the full year pass-through effect of sulfur costs on sales to be approximately $220 million. Fourth quarter adjusted EBITDA is expected to land in the range of $54 million to $58 million, with regenerated sulfuric acid volume up compared to the year-ago quarter and virgin sulfuric acid volume lower than in the fourth quarter of 2025; a turnaround with a projected cost of approximately $3 million is deferred into early 2027, when the company expects to execute 6 turnarounds at its sulfuric acid plants.

  • Third-Quarter Adjusted EBITDA Growth Above GuidanceThird-quarter adjusted EBITDA was $61 million, up over 6% compared to the third quarter of 2025 and above the high end of the guidance range. Growth reflected higher volume and sales, favorable pricing, and the contribution margin from Calabrian, despite higher turnaround activity and costs.
  • Strong Third-Quarter Sales GrowthThird-quarter sales were $309 million, up $104 million, or 51%, compared to the year-ago quarter. The increase was driven by higher sales for virgin and regenerated sulfuric acid, favorable pricing, the Calabrian acquisition, and approximately $67 million of higher average pricing associated with the pass-through of higher sulfur costs.
  • Positive EBITDA Volume and Pricing ContributionsExcluding the pass-through effect of higher sulfur costs, net pricing increased adjusted EBITDA by $5 million and higher volume contributed $15 million to the year-over-year increase.
  • Raised Full-Year 2026 Adjusted EBITDA GuidanceThe company raised full-year 2026 adjusted EBITDA guidance to $208 million to $212 million, a $9 million increase at the midpoint compared with the guidance provided in early August. The increase was primarily driven by operating performance, with the balance reflecting the deferral of a turnaround into early 2027.
  • Raised Full-Year Sales GuidanceFull-year 2026 sales guidance was increased to $1.05 billion to $1.07 billion from the previous range of $1.02 billion to $1.06 billion, reflecting positive demand, favorable pricing, and the expected pass-through effect of higher sulfur costs.
  • Improved Free Cash Flow and Earnings GuidanceAdjusted free cash flow guidance was raised to $50 million to $60 million from $45 million to $55 million. Adjusted net income guidance was increased to $70 million to $85 million, and adjusted diluted net income per share guidance was raised to $0.63 to $0.77 from $0.58 to $0.72.
  • Favorable Regenerated Sulfuric Acid DemandThe company expects continued high refinery utilization and favorable demand for regenerated sulfuric acid. One customer asked to move a turnaround originally scheduled for the fourth quarter to early 2027, supporting fourth-quarter regenerated sulfuric acid volume that is expected to be up compared to the year-ago quarter.
  • Stable Gasoline Demand and Higher ExportsDespite higher gasoline prices, gasoline demand remained stable and gasoline exports were up 5% year-over-year. Strong refining margins are leading some refiners to defer maintenance to maximize production.
  • Positive Mining and Industrial Demand OutlookThe company sees positive demand through year-end and beyond for sulfuric acid used in copper and borate mining and sulfur dioxide used in gold mining. Management also cited strong demand fundamentals for virgin sulfuric acid and sulfur dioxide in mining and industrial applications.
  • Calabrian Integration and Synergies On TrackJust over four months into the Calabrian acquisition, the integration process remains on track and is ahead of schedule in some areas. The company said the Calabrian team is enthusiastic and engaged, and delivery of expected synergies remains on track.
  • Strong Liquidity and Positive Cash GenerationYear-to-date adjusted free cash flow was $32.4 million. Available liquidity was $167 million at September 30, consisting of $71 million of cash and cash equivalents and $96 million of availability under the ABL facility.
  • Leverage Remained StableThe net debt leverage ratio was 2.1x, essentially unchanged compared to June 30, and included only one quarter of Calabrian in the trailing 12-month period.
  • Pricing Power and Contract ProtectionManagement said the company has a track record of raising prices as contracts roll off, with contracts also linked to inflationary indexes. Contracts renegotiated during the year have produced positive outcomes, and the company expects good pricing power if demand remains strong into 2027.
  • Long-Term Growth OpportunitiesThe company identified growth opportunities from increasing demand in mining applications for sulfuric acid and sulfur dioxide, as well as virgin sulfuric acid demand across industrial applications as onshoring of industrial activity continues to increase.
  • Capital Allocation and Share RepurchasesThe company continued organic investment, including expansion of Gulf Coast storage and logistics, completed the accretive Calabrian acquisition, and returned capital through share repurchases. After repurchasing $2.7 million of shares in the third quarter, it plans to allocate up to $20 million to opportunistic share repurchases in the second half of 2026.
  • Tight Supply Chains and Limited New SupplyManagement said supply chains remain tight, with limited inventory in the system for virgin sulfuric acid and regeneration. It also cited continued strong demand and no appreciable new supply coming onto the market in relevant mining segments.
  • Fourth-Quarter Adjusted EBITDA OutlookFourth-quarter adjusted EBITDA is expected to be in the range of $54 million to $58 million. Regenerated sulfuric acid volume is expected to increase compared with the fourth quarter of 2025.

ECVT Earnings History

ECVT earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)0.17-0.28――
Nov 05, 20262026 (Q3)0.210.230.1921.05% (+0.04)
Aug 05, 20262026 (Q2)0.190.210.1275.00% (+0.09)
May 05, 20262026 (Q1)0.050.110.011000.00% (+0.10)
Feb 26, 20262025 (Q4)0.150.280.280.00% (+0.00)
Nov 04, 20252025 (Q3)0.150.190.1435.71% (+0.05)
Aug 07, 20252025 (Q2)0.100.120.120.00% (+0.00)
May 01, 20252025 (Q1)-0.030.010.04-75.00% (-0.03)
Feb 27, 20252024 (Q4)0.240.280.2227.27% (+0.06)
Oct 31, 20242024 (Q3)0.170.140.19-26.32% (-0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed